Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
pmontx16... It's hard to say.
Unless the "very longs" were able to cost-average down, they won't be able to get that 30-1 back.
I'd say at $1.50-ish the risk of investing today is well above 50/50 for big multiple profit.
My best (personal) analysis is now $42-$48/share. Which pre-split is poor at best for an investment period of 8-10 years.
My thoughts are based on the present business model as it's been stated from MDT, and the current COB. I'd have more market material to work with, and better information, if TMDI could talk about what they've been doing for the past year.
FYI - I'm live from Carrollton, TX.
Good luck to all. Regards,BK.
Revival? I'm a contributor.
As hard as I try.... to be objective and call out those who repeatedly are not. You seem to not appreciate the effort. I want facts, and I want supported arguments with clear explanations and sources where possible.
Opinions sited as facts, without the entire (full) disclosure of the subject is not objective.
I'll agree to that.
Good luck to all. Regards,BK.
Titan History (current events), reading (Titan development agreements), and math (Possible Titan BO elements).
Try again. You're wrong about all 3.
Again, this is a different company than even 2 years ago.
Milestones are completed by mutual agreement. And again, I've already shown where MDT would be in a disastrous position should Titan complete Milestone 4 and pay off the loan. You have to keep all the facts straight to understand the situation MDT is in. I don't think they let the 4th milestone get completed without an extension or additional conditions from letting Titan go back on the open market to negotiate with another competitor.
Regards,BK.
I'm only here for the cancer cures. The laser is an activation device but not worth the long-term cash investment, unless we get revenue sharing % and shares of the pharma that buys the cancer division.
And it would be interesting to know what the pharma would consider fair-market value for the BO. The lawsuits would be many against the BOD, if the BO wasn't above $50/share considering the future application of all cancers that 1433 and Ru(II) can address. And any effects as a therapeutic. So many potential avenues for the good of mankind, and of course revenue. But, mainly for mankind.
JMO.
Good luck to all. Regards,BK.
I almost feel bad...
You're using the wrong tool to represent you point(s) about this company - at this time. Charts are great for a company that's not in a complete state of flux. And this is a completely different company than 2 years or 5 years ago. While the company was in terrible condition all those past years, it's not the same at this time.
AT ALL.
Can you say this company is NOT moving through several change conditions from which a historical share price chart is applicable?
It's called situational awareness. Try it sometime.
This company is different since the MDT development agreement.
The share price is being completely manipulated.
Good luck to all. Regards,BK
I'm absolutely correct.
When you try to present "innocently?" the historical perspective as if it's relevant to today's conditions, that's called misrepresenting the whole truth.
Further, I see no chicken breast videos. That comment I would assume means that you have no appreciation for the full rotation and end-effector flexibility, control and dexterity. A single line using a cautery tip would be pathetic at this point in development, but we're far beyond that.
To your credit, I believe everyone that reads this board is in complete agreement with the debacle that was McNally's profer of the RS. I'm going to say it was the main issue of his downfall, and subsequent removal. The BOD had to remove his decisions going forward due to the exposure of fiduciary responsibilities. IMO. His history was an irrefutable litany of poor planning and execution regarding the uplist to the NASDAQ, and disregard for shareholders rights. Further, MDT's arrival may have had something to do with that too. They've been on scene well before the June announcements.
For me, "I've always said the key to our IP, and main value of our technical accomplishments is b/c of Jasminder Brar, and Dr. Perry Genova." Mr McNally gets credit for hiring him, but not much else. I'd be happy to acknowledge anything else of substance on his part, if I was aware of anything.
Cash flow, vs cash-on-hand is different but we're good until the end of '22. Cash flow will be based on additional development agreements or licensing of IP. The company has nothing to sell. The POSSIBILITY of Co-licensing isn't necessarily a bad thing, considering MDT HATES sharing market revenue and license agreements with another competitor. Which IMO would be detrimental to MDT/Marth's reputation. Especially trying to justify the inaction to the MDT BOD of another company using IP that which MDT could have locked up exclusively. So I'd say MDT comes up with more cash, or they suffer the consequences from their lack of commitment. They can't have it both ways. Either fund TMDI, or TMDI funds itself in the open market. It's cheaper and absolutely secure if MDT funds us. The other is Pandora's box.
"Hardware design freeze was a lie according to a recent post by 66 Mustang." I believe 66. I don't know the condition of ENOS at the time, or whether it could have passed the requisite testing and safety certifications.
Insiders holding actual shares is of no consequence as they have incentive options as part of their compensation package. That's just shareholder Xanax, but not a requirement.
"I do believe this company gets bought out. But it will be a mercy buyout and completely on the terms which med Tronic dictates. Mac should not be at the head of a negotiating team here." Mc's not in charge, it's the BOD. Which is why all of the recent new additions to mitigate any future lawsuits based on perceived market value. Your predictions would trigger massive law suits as compared to the market value of other mergers and BO's in the RAS space. Your's isn't an objective comparison, only a personal opinion. If you take into consideration other BO's and market valuations - I don't see how you can be where you are in your estimates. And your estimates don't take into consideration the time value of buying IP, or the greed factor of WallStreet. You're missing many, many real elements that exist, and which could be real factors in the BO value.
It will be very interesting seeing how this unfolds.
Good luck to all. Regards,BK.
Why so much gloom.....
It's terrible that the 4th milestone was delayed, but as I've said before there's a completely logical possibility.
The 4th milestone completion is the key to unlock the question(s) as to what's next with TMDI.
THE LOAN. With the most ridiculous provisions for a minuscule $1M amount, to pay off a consultant suit, and put all of the company IP as collateral. If that's not the biggest, most obvious LOOK HERE b/c this is what we're doing and can't tell you about it. I don't know what else they could have done with the gag-clause in place.
If the 4th milestone were to be executed on time, and no new amendments or addendums to the develop agreement - then the loan could be paid in full. Then TMDI is free to do business with anyone of their choosing.
This would put MDT at great risk, of sharing the IP that which they have licensed. Which at the time of the announcement was 10-14 patents? Martha hates that - his words. He's the new CEO b/c he was the former head of MDT Acquisitions. Or worse, another RAS med-tech company jumps in front of MDT. Don't think MDT will permit that so they said, "hey, tweak this" before we consider the 4th milestone completed. "It's ok if it takes a few months longer." What I think it means is "we don't want you to have the option of paying off the loan at this time." "Keep working on the 4th milestone."
Hard to know the real truth, but in spite of all the negativity and faux bashing of the condition of the company, NO ONE can deny the company is in the best shape financially and down the path of progress on ENOS.
Better than at any other time.
I will feel no sorrow for anyone selling between now and next summer. B/c no one knows what will happen tomorrow, next week, or next month. Once you sell, you will need to sit for 30 days for the wash sale rules..... Somehow that point always seems to be missing in the sell now and buy back later messages.
Good luck to all. Regards,BK.
SP Tanking - need your help?
You think all these extremely small lot share trades reducing the sp going into the close of the day, and AH are random?
All anyone needs to do is look at the trades as they occur to see for themselves. The facts are shown in the list of trades being made.
This company doesn't tank its sp all by itself. And your statement may be one of the biggest fallacies purported on this board.
My suggestion would let it ride for 30-60 days and see where the sp would really land. My guess would be 3x-5x higher. And that would be "all by itself." The REAL definition of the phrase.
You're as complicit as a few others trying to promote a false narrative about the true market value of this company, as the sp reflects the artificial trading environment being played daily.
Good luck to all. Regards,BK.
The Last Milestone.....
I think everyone is missing one very important little detail.
The LOAN.
The loan can be paid off after the 4th milestone. If, and when it's paid TMDI has no more handcuffs.
I would venture a guess and say "that would be the worst case scenario for MDT." They want this done, finished and approved before any announcement(s).
So either TMDI needed more time to finish what ever was redacted in the agreements, or MDT asked for more time for several reasons.
They need more time to evaluate the market?
They need more time to evaluate the device, besides Dr. Estape's review?
Something else needs to be coordinated between MDT and TMDI besides the end of the 4th milestone? Like... a simultaneous BO of a separate, but useful RAS company?
Oh the major league bellyaching... Puuuulllllleeeeez. Blah, Blah, Blah. Save the drama for your Mama.
This is an R&D RAS device company. This sh!t just doesn't pop out of the bottom of a Cracker Jacks box. You can't just order it on Amazon. If it was easy, someone else would have done it by now....
60 days. Get over it.
Good luck to all. Regards,BK.
Belize, Illegal?
Really? Illegal is a sick bird. Try unlawful.
Also, dropping $.12-$.15 in one or two trades after hours isn't sp manipulation?
You're in denial. Not the river in Egypt.
Good luck to all. Regards,BK.
Bill Gates - Backs Vicarious?
Near as I can tell Gates hasn't invested as much in Vickie, as MDT has invested in TMDI...... Oh well.
02.15.19 On Thursday, Vicarious Surgical announced that it had closed a $10 million round of funding led by Bill Gates’ Gates Frontier. The company will use this money to continue to develop its technology combining surgical robots and VR. Not absolute details, but the article is specifically vague about the exact amount from Gates, so all we can assume is it's not the entire amount raised.
08.10.20 This may seem like science fiction now, but after raising $13.2 million in fresh funding, Charlestown-based Vicarious Surgical is one step closer to making this vision a reality. The round was led by E15 Capital managing partner Philip Liang, with participation from existing investors including Bill Gates and Khosla Ventures. Liang will join the company’s board of directors. Again, not the entire amount raised.
03.15.21 The SPAC deal’s total also includes a $115 million private investment round that has attracted the medtech giant BD as well as Vicarious’ previous high-profile backers, including Bill Gates, Khosla Ventures, Innovation Endeavors and E15 VC. AND AGAIN, not the entire amount raised. And this last round is delayed until lawsuits are addressed.
Some on this board would lead the uninformed to believe MDT's meager investment isn't worthy. But that initial investment would appear to be more than a "high-brow" source, of recent questionable repute, to a possible competitor.
I'm open to any additional contributions that state otherwise, or add further numeric details. I ask for the whole truth. This is all I could find.
Sad. It would appear that we aren't being presented with the whole truth.
Good luck to all. Regards,BK.
Most importantly control what you can......
which would be to schedule testing for software and hardware, and continue to develop IP.
Both of which will continue to build value and create pressure on those that wish to compete in the RAS market.
The further along we get with ENOS and our IP, the shorter the distance to some form of action to acquire our company.
Someone keeps harping on the sp, and the value of a few hundred million. I call BS. SERIOUSLY....
What's the value of ISRG's SP? Sure, it works. But it's not for sale. Vicarious is supposedly merging with D8, once those lawsuits get cleared up. Wonder how long that takes, and delays it creates?
My point is our value is NOT based on our current sp. It's what ENOS does near-term and what our IP can do for the next 20-30 years. Over the course of the next 2-3 decades, I would speculate that miniaturization will have an amazing effect. But you still have to own the base patents from which to miniaturize.
Our value is tied to ENOS 1.xx near term. However our BO value should include - by extension ENOS 2.x, 3.x and the future value of the additional applicability of our IP. While this is speculative, we have a clearly defined road map as it has played out for ISRG. We just have a better mouse trap.
I think there will be Wall Street participation in the sp run up, b/c there's no stopping it. It's also highly speculative that ISRG would take a swing at TMDI. That's not out of the realm of possibility. I also think MDT will do their legal best to keep the sp from running away, which we saw with Mazor. Also, I can foresee wild speculation in the open market as to the final BO sp b/c we are currently publicly traded. I hope. For me, it's only a question of when - not if. IMO.
Previously, I've made my case for $38.50/share. I'm revising it upward to between $42.00-$48.00 per share. Using approximately 150M outstanding shares at the time of BO announcement. I'm increasing the number of total outstanding shares for this estimate, b/c if my estimate is incorrect (if the actual count is lower at the time of BO) - it will be to our benefit. But (IMO) 1-2B$ is just silly talk and contrary to the defensible value of 20 year IP, the time value of buying IP instead of organic R&D development, Mazor, eENT, and the individual value of ISRG SP.
Bring on the arguments, but PLEASE bring the supporting substantive details with it. I haven't heard any good, or reasonable supporting arguments yet for a lesser sp.
Good luck to all. Regards,BK.
Come On! Drop this to $.11 or $.12 so I can pick up another 100K.
Bunch of pussies. Just screwing around with the sp. Get a real job.
a$$0s
Regards,BK.
Magnus - If you really want to know....
send a message to McNally. Between you, hear no evil, believe no evil and can't believe he said that no evil, nothing seems to get through to any of you Stooges. Nyuk, Nyuk, Nyuk...
Good luck to all. Regards,BK.
No Not Weird - Fully Vested......
upon change of ownership may have no financial effects to those who leave before the BO. Depends on the terms of their employment agreement. Which is why it doesn't matter b/c you have no control of any aspect of this company. And I'm really glad!
Leaving this company at this time would appear to be odd timing, but not weird. No one knows their personal circumstances. At this time, you're pretty clueless if you're not aware of stock options being offered at the time of employment, or extended for a specified period of time after you leave a company. It may look similar to a deferred compensation clause after a contract has run its course. How do you think all these profession sports teams pay those players $100M's of dollars? It may have a similar structure or result like a pension or annuity. Thank you Bobby Bonilla.
Again, you need to better understand generic employment incentives, as they would apply to this investment and the myriad of terms in "free agency."
Good luck to all. Regards,BK.
Ohnototo, I beg to differ.
You're flat out incorrect. MDT does not, and can not control ANY aspect of actions by the BOD. It is completely contrary to the fiduciary duties of any officer of TMDI. As such, any activity (any action) that would meet the definition of a material event is required to be made public information.
MDT has an attendant permitted during TMDI BOD meetings. With the stipulation that they be excused during discussions that would be competitive in nature or compromise lawyer/client privilege.
Where did you read they control the BOD? WOW. Please, read the agreements.
Good luck to all. Regards,BK.
Neither you, or I (or anyone else) knows what she did/does for her compensation. Get over it.
You clearly need to understand this investment better. Perhaps start by researching the "free agent" concept in sports.
Good luck to all. Regards,BK.
Why do you care? You have no control...
of anything as it relates to this company. And I'm very happy about that!
I stand for what ever it takes to get the best person available. Period. 1 person makes a HUGE difference. Jasminder Brar comes to mind. So does Dr. Genova. Not to mention all of the creative minds that have been recently added to the Engineering Dept. It only takes 1 great idea in this market segment to be worth $100's of millions. And you want to complain about a few 100,000 options. Minor league thinking in a major league market?
Who would invest in a company and not be COMPLETELY AWARE that there would be options? How inexperienced/uninformed can you be??? And then try to assign blame for your lack of understanding??? Clearly you don't understand how, or what it takes to run a company. Let alone an R&D company with a highly capable prototype in an industry market segment that is screaming for competition. Not to mention the open arms of thousands of global customers.
Further, I don't hear you complain AT ALL about the compensation over at vicarious. Would that be considered by some to be a 1-sided narrative?
Your efforts to make an issue out of NOTHING are comical.
Not the droids your looking for. Move along.
Good luck to all. Regards,BK
Another raise? With $53M on hand?
And another $11M within 90-120 days? With enough working capital to get them through 2022? Please, feel free to correct me if I'm misstating that amount or the length of time the amount covers. It may be more, but not less.
Me thinks (yes I do often) the lady doth protesteth too much.....
And too often, and incorrectly, and deceptively, and dishonestly, and without professional certifications or licenses, and with hidden agendas, and without research references, or sources. With lazy excuses to bring up reducing the number of outstanding shares, just so you don't have to hit 3 extra keys on a calculator?
Don't see more dilution with MDT in the picture. Why, b/c of the previous raise for $18M and the bought deal. If MDT wanted TMDI to raise more capital, they could have put a higher amount in the development agreement conditions. But...... they didn't.
Good luck to all. Regards,BK
If your point is.. you can control time, sure. Can't stop it, so ignore it? Why not acknowledge the recent and new chapters? Too much, too soon? Need more time to complain? You've had 6-8 years. From your posts, sounds like you miss the "good" old days? I don't.
The title of the most recent chapter in your book would read, SOB! We have more $$$ than ever before, and a partnership with MDT. Dammit!
All I see from your posts are complaints about something that hasn't happened. Who complains about something that hasn't happened yet? DUDE! Find the happy space in this investment.
Why are you so concerned about how much Mc makes? Do you care what I make? Bezos? Gates? You don't care about how much Sachs, Kahlifa or Styka make. And they only have a handful of patents? No one builds something without a solid foundation if it's going to last. USPTO says........ hmmmmmm? Not so sure about these. Probably stepping all over TMDI IP. And now MDT IP. That would a MASSIVELY HORRENDOUS MONUMENTAL DISASTER (all used correctly I might add.)
I think you need to find a hobby and not tell us about it.
Good luck to all. Regards,BK.
It's not incorrect if you add more chapters to the book. Many books have had addendums, and amendments included for new editions. Same subject, new information.
If you choose to write THE only book about this company 1 time, it will be incorrect, and out of date.
Time doesn't go backwards. Everything gets updated.
The telling of this company isn't etched in stone. Yet you keep telling the story as if it only occurred sometime in the past. You repeatedly refer to the past, and not the recent past.
Hard to go forward when you're always looking behind. Kind of like shorting a stock and watching it go up.
Good luck to all. Regards,BK.
Few, if any are laughing.
You have to care first, or take what's said seriously.
0-fer...... a longgggggggg while. Not keeping score.
Chafing cream on sale for share price irritation. $1.73 on sale, buy-one-get-one.
Good luck to all. Regards,BK.
Between 6:30-7:00 2 trades...
1 for 10 shares, the other for 8 shares to take the sp down $.10.
Don't tell me or anyone else that cares to look, that this is not an artificial sp, and is very clearly being manipulated.
What are you using to polish your crystal ball? Mud from the Delaware river works on horsehide. Wonder what works on horsesa$$. Honey?
I've also heard it's good if anyone is suffering from sore a$$ from wearing your panties in a wad for months on end, chafing, and other share price irritations.
Good luck to all. Regards,BK.
Reply 130364: Shorts, thank you for that.
There have been several interesting "finds" as the descriptive language has changed over the last 12-18 months.
I appreciate all that have provided those subtle, but substantial company statements.
Good luck to all. Regards,BK.
Helen? You keep forgetting that some have their shares in IRA's.
You can't even tell everyone the possibilities of your failed premise.
No tax loss there.
Forgot to tell the entire story.....again.
Good luck to all. Regards,BK.
Timing and free advice,
SELL,SELL,SELL, as Jim Cramer would say. But, he doesn't advocate buying back in after the wash sale period. Does anyone think this recent flurry of free advice is based on altruism? On a public message board? When the music stops who's not going to have a chair? I mean, we all can't buy back in lower. Someone's going to be left out. Right? I do not wish for anyone to have a detrimental experience based on what I write on this message board.
Further..... regardless of the number of shares traded recently, the sp hasn't gone much further from $1.60. Why? Someone, or a group of someones are buying up any shares offered and IMO those shares won't be coming back into the market. Could the sp go down further? Yes, a possibility. However, within this recent time frame it hasn't. So there would appear to be an artificial floor on this sp.
THE main issue with this buying and selling is called timing. Someone is trying very hard to convince those that are curious or wish to get a few more shares cheaper. We all would welcome that if it occurred. But the catch appears to be based on specific timed events, as it's been posted. So I want to know who can predict what is going to happen a few hours from now, tomorrow, next week, or next month? The risk of selling is based on NO ONE knowing what may occur/happen at anytime in the future with this company.
What IS known is that our company has an agreement for development, the details of which have been redacted with the largest medical device company in the galaxy, soon to conclude in September. Check that date, as I may be wrong (but you understand my intent). Also, MDT has licensed ONLY ~10% of the patents at which time there were less than 100. Also, I'm not sure if MDT would license an unapproved patent not issued from USPTO, so the licensing of IP is also a guess. Can't imagine paying for IP that's not protected by an official patent, but (I guess) it's in the realm of possibilities. Also MDT has very well known history regarding partnerships and acquisitions. It's speculative to think they will BO our company. MDT has only done it more than 60 out of 65 times? Anyone, please feel free to add the exact numbers to this approximation, as I'm not exactly sure of the specific number of acquisitions. I AM SURE it's a damn big number, and a very high percentage of their partnerships. I'd say that's a consistent pattern of business behavior. It doesn't mean it's absolute, but hey - it's called dating for a reason.
What is absolute is the known RAS environment, and the competitive capabilities of those that are known to be in this market segment. Many of which would clearly benefit from our IP, working know how, and RAS single port prototype. B/C so far there's only ONE (1) company that's doing RAS in the market segment where our prototype will operate (pun intended). This would appear to be a lucrative opportunity for the next RAS device when it's available for this market. IF you own shares as new information becomes public...
One side of this argument is based on guessing, the appearance of knowing the future events of this partnership, the competitor business strategy, and certain calendar dates - all in an effort to reduce the sp. The other side is the distinct possibility that some of those that may consider selling now won't be able to buy back lower if there's low trading volume.
I can't predict the future of events in this market place. My vision is based on my abilities to formulate possible outcomes from past events, the known conditions within the investing environment, and based on the greed of those that wish to duplicate the same type of share price appreciation that has happened with ISRG. Each, or in combination are possible.
Sitting in the audience watching this unfold is an active decision. Selling, thinking you can predict the future? Being able to buy back in lower after the wash sale period? Or the sp doesn't stay below your sale price and it rises and stays above.
Makes me want to ask "what are you using to polish your crystal ball?"
I'm sitting and watching.
Now you know what I think, and why.
Good luck to all. Regards,BK.
The other board is fine. This board too, if you know how to ignore the lunacy.
Elsewhere we don't have to deal with the abject manipulation of some that can't comprehend tax issues, and continuously being told one-sided information. Leaving out the entire set of conditions from which "advice" is being given is disingenuous at best, and outright dishonorable. NOT to the benefit of the uninformed.
These are not the droids your looking for. Move along.
Good luck to all. Regards,BK.
Honey, 2 things. First, Mc can't keep a lid on the sp. That's unlawful. There's an Ethics committee, and every officer in this company has a fiduciary duty. It's too easy to prove. Get off of that line of BS. And BS does not mean business strategy. And further to Mc's ability to have any effect on the sp: Did you ever think why the language in the development agreement wasn't redacted regarding the review and approval by MDT of any announcement/advancement/update that pertains to these legal documents????? It's b/c they wanted everyone to know Mc can't without their review and approval. I hear a hissing noise. It must be the air escaping out of your hot air balloon.
2nd - No one is taking ANYTHING you propose seriously at this time. Why? No one knows what the plan is, or the time line for MDT to make an announcement. And from what I read on this board EVERYONE is holding their shares, and accumulating as they evaluate the current sp to continue to dollar-cost-average down. Not by increasing their risk, by the selling.
Go preach to the congregation at the Church of the Holy Great Harvest. No one cares if your PIZZed, pissed, angry, or your panties are in a wad. Further, your tax advice and selling/buying advice can get you in serious trouble. In case your not aware (obviously) we all know about selling and buying back later. NOT GOING TO HAPPEN, due to the timing of the 4th milestone and other anticipated activity that has the potential to move this stock quickly far above where it sits at this time.
Whining for help to do your bidding (pun intended) isn't going to happen. Someone with deeper pockets than all of us combined is keeping this around $1.60.
Good grief! Tell it to your dog. He'll listen... but he won't sell.
Good luck to all. Regards,BK.
Honey, your messages are starting to sound like the teacher in the Charlie Brown movies.
We'll wait and buy on the dips, if/when they occur.
We're not the droids your looking for. Move along.
Regards,BK.
Honey, again....take it up with the BOD. We aren't responsible for what ails you.
Regards,BK.
Honey, Shareholder value? You thought that the sp was going to miraculously stay at $3.50ish, or levitate from the available funds/capital that the posters on this board have available?
You're dreaming. You don't have the cash, and neither do most (if any) that read this board. Everyone's waiting for additional new information that will drive this sp higher.
You blame all that you dislike about this company on those of us on this message board. Get a clue.
Good luck to all. Regards,BK.
Honey, take it up with the BOD. You're trying to blame us for what was passed, and we don't have the juice to change what the majority shareholders (a.k.a. friendly) do on behalf of whomever purchased the 10's of millions of shares at or above $2.50 and the $18M raise.
You need to know who your audience is, and it's not us.
We blame you for your incessant investment advice, in spite of the fact that you're not a licensed financial professional, broker or planner. Invest your own money as you will, just quit instructing us to follow your "advice," b/c you've been as wrong about this stock as most of us. It's just we're willing to own our decisions, try and fix it, and not incessantly whine and complain about it.
Good luck to all. Regards,BK.
Devicerep888, that's a he!! of a good point about the state of affairs of Mazor and the spine surgery market at the time of the BO.
So, MDT felt that occupying the space and owning the IP was strategically important going forward. Not b/c it was operating on all cylinders (pun intended).
Not too far from similar conditions as we are in presently.
The ability to cheat the amount of time it takes to create IP and defend it is the true long-term value of this company. IMO. And MDT would want all of the IP from which to turn into a weapon against any other form of RAS device with similar features, functions and controls. Makes our IP even more valuable. Cant' really compete or defend with just 15-16 patents b/c of all the subsequent IP by extension of capability(ies) and overlap of any future development. IMO.
Good luck to all. Regards,BK.
So in order to compete.... Rocko, I like how you present each point and connect them. It appears very possible. I really hope it's true.
I'd like to restate the following in support of your points, and a larger BO than some have stated recently.
Medtronic can't get where they want to be soon enough with only 15-16 patents. Unless you think they can build their own version, which would take +350M and another 4-5 years. B/C they'll have to develop their own R&D for the parts that aren't covered, then apply for the patents, and then see if they are awarded. 4-5 years minimum.
For every year TMDI can save MDT the agony of not being able to enter another new RAS market segment is worth $1B$.
The time value of buying IP. Especially TMDI's IP. It permits MDT to ROLL ahead 4-5 years of their ability to create defensible IP.
TMDI's worth more than $5B.
A) 20-40 year defensible IP, & applicability for multiple applications = $3-$5B
B) Time value (time saved) approx. $1B/yr = 3B-$5B
C) R&D (Titan Labs) approx. $350-$450M/yr
D) Total revenue projections over 20-30 years, only ENOS ~ $23B-$24B
$1.3M x 650 units/year = $845M x 25 years = $21B not including disposables and maintenance.
E) Mazor +$5B for how much projected revenue over 25 years?
F) 5% of current MC of ISRG = $5.7B. Using ISRG's MASSIVE 20x multiple. (That's the proper use of that word).
G) Could vicarious be having trouble getting their applications approved through the USPTO? Now that MDT has licensed IP from us, they would be able to make it very expensive, and both MDT and TMDI could collect penalties and fees if they encroached on the shared IP.
H) Could Colubris be a part of any future acquisitions? Do I recall correctly that the President was seen visiting TitanLabs, sometime in the recent past? Please correct me if that's not true. During the video presented by Dan Kim, at the 15:45 mark - those sure look like TMDI snake arms. The timing appears odd though b/c the presentation was done in 2019.
https://veritastv.org/programs/2019-srs-day-1-danielkimmp4-bfacac
I think I'm in the ballpark ($5.7-$11B) of true market BO value. I think the Mazor deal is relevant, and important to any action toward a BO. IDC what the current share price is. It's being artificially manipulated. Which is why the sp sits where it is until some form of solid confirmation. Don't ask if/when.. no one knows.
There aren't many places to shop for a truly unique SP RAS device in this galaxy. And no NASA/Uber to get you to a different galaxy.
Good luck to all. Regards,BK.
FD, I would. Someone has to inform those people of the competition. Who wouldn't want to know the competition has +160 patents and that those patents, and others could ROLL Vicarious tech into penalties and future license agreements to those that hold existing patents. Could be the reason(s) Vicarious only has 4 approved from USPTO. This could become Verb 2.0.
Good luck to all. Regards,BK.
Competition??? +160 vs +4(maybe30?)
Has vicarious been developing for 10 years too? I'd say it could be likely that those submitted patents are running into issues at the USPTO. ISRG? MTD? TMDI? Verb?
Sincerely. Good luck to all. Regards,BK.
USING LIGHT TO TREAT DRUG-RESISTANT TUMORS
National Science Foundation funds investigation of UTA researcher’s cancer photodrug.
https://www.uta.edu/news/news-releases/2021/06/29/using-light-to-treat-cancer
Thank you to CancerSlayer for posting on stockhouse 07.11.21.
A chemist at The University of Texas at Arlington is developing a cancer medication that uses light to target and destroy tumor cells in a process known as photodynamic therapy (PDT).
Sherri McFarland, professor of chemistry, and her team of researchers have developed a chemical compound containing the transition metal ruthenium. When ruthenium absorbs light, it produces a powerful oxygen reaction. When the ruthenium-containing molecule, light and oxygen all interact with one another, they become highly selective cancer-fighting agents that do not affect surrounding healthy tissue.
McFarland’s photodrug, TLD-1433, is currently in a phase II clinical study for patients with recurring bladder cancer that has proven resistant to traditional therapies.
“TLD-1433 is extremely effective at killing cancer cells and is orders of magnitude better than similar compounds designed to achieve the same results,” McFarland said. “In general, these types of photosensitizers are oxygen-dependent. While TLD-1433 is very powerful when oxygen is present, it can also destroy certain types of cancer cells in hypoxic environments where oxygen is lacking.”
The National Science Foundation awarded McFarland a $440,000 grant to investigate the photodrug’s unusual effectiveness in low-oxygen environments. Her research team has hypothesized that TLD-1433 operates by an unknown mechanism that is facilitated by oxygen when it is present but does not require it.
“The fact that some of the most aggressive and drug-resistant tumors are hypoxic is a challenge for cancer therapy in general as well as PDT,” she said. “If we can discover an alternate mechanism that persists even in low-oxygen environments, that would mean these agents could be used to treat hypoxic tumors and allow health care providers to apply light-based therapy to the most difficult-to-treat tumors.”
For patients with non-muscle invasive bladder cancer like those in TLD-1433’s phase II clinical study, photodynamic therapy provides hope when other cancer treatments are unsuccessful.
“The study enrolls patients who have failed standard therapies. They would have already had immunotherapy and multiple surgeries, but their cancer persists,” McFarland said. “The recommendation at that point is removal of the bladder. That is what they are facing.”
A cancer survivor herself, McFarland said her goal is to provide more treatment options for cancer patients, particularly for those whose cancer is unresponsive to traditional therapies.
“One area of focus now is to gain an understanding of why TLD-1433 works so well. Then, we can design even better light-activated drugs in the future,” she said. “If we can make a photodrug that is potent and selective, providers can dose at much lower levels, making the medicine both safer and cheaper to produce. More importantly, at lower doses, we could minimize side effects for the patients.”
A key element of the creation of potent photodrugs is experimentation with new chemical compounds. On McFarland’s team, this task falls to Wesley McDonald, a senior undergraduate researcher who has worked in the lab for two years.
Wesley McDonald, research assistant in McFarland
“My work is exploratory. I synthesize brand new chemicals so that we can see which combinations work and which don’t,” McDonald said. “I’m the first step on the ladder to producing more effective PDT treatments for cancer patients.”
After attending one of McFarland’s guest lectures in the College of Science, McDonald approached her and asked if she had any open positions in her lab. A former pre-med student, McDonald said working with McFarland influenced a new career path.
“Dr. McFarland gave me a lot of responsibility, and I fell in love with research,” he said. “After graduation, I hope to continue working here and earn a Ph.D. from UTA.”
When he is not testing new compounds, McDonald creates batches of TLD-1433 to assist with photomedicine exploration in labs across the United States and beyond.
Pending results from the clinical study, McFarland hopes TLD-1433, along with other photomedicines, becomes a leading treatment option for patients with aggressive and unresponsive cancers.
“A lot of people don’t know that there are alternative treatments like these light-based therapies. Even your typical oncologist may not know about PDT,” McFarland said. “When we think of cancer treatment, we think of chemotherapy, radiation, immunotherapy and surgery. But if you have a tricky form of cancer, there are a number of emerging alternative therapies available.”
Good luck to all. Regards,BK
I can't fathom anyone considering an investment in a manufacturer and not consider the defensibility of the IP. That's the master link to a manufacturer's ability to bring that product to market, and the bases from which it will build further future versions from the basic model. That's likely the most critical and MASSIVE error all ROLLed in for not considering the downside risk. IMO.
To take the downside risk possibility to the journalistic depths that it deserves - TMDI might not have the heft/girth/enough dry powder for a fight, but if MDT holds those patents for snake arms, connectivity, performance and function...well both MDT and TMDI could be collecting royalties from Vicarious. Vicarious could be paying for the development of ENDOS 2.0, 3.0, 4.0, 5.0. Or worse V1.4, 1.5, 1.6, 1.7, and so on, and so on, and so on.......
DOUBLE WAMMY.
Keep asking those hard-hitting deep journalistic questions. You're a credit to the objectivity of this board.
Good luck to all. Regards,BK.
Keep in mind, that we're all looking for that certain thread that will lead to a conclusive nugget that we're absolutely certain of our convictions.
However, in this business environment the "business tool du jour" is the NDA. And that keeps the details from being public information. And another recent development has been the shared of other BO's that included a "No Shopping" provision while reviewing an offer. Interesting.
Should nothing happen after milestone 4, and Titan pays off the loan then it's a clear field for anyone to enter into the fray of this speculation. It doesn't mean an absolute that a raise is forthcoming. It may.... IDK, and it's a only someones guess. Sure, I'll acknowledge that if they use up their ~ $50M, then they will need more $$$ until ENOS is ready for market. But so far, MDT is in the middle of this and they have openly declared that this is the way they intend to do business going forward.
And we all know Wall Street is greedy, and ISRG is the 800# gorilla in the room. So this is far from over, but it could be very quickly. As has been described in detail for all to consider.
Good luck to all. Regards,BK.
And I'll hate that - if it happens too. Just keep in mind, we all get the same BO number. I'm not rooting for anyone to lose money, along the way, or in the end. Not my style.
Good luck to all. Regards,BK.